Basic Study
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Nov 27, 2020; 12(11): 976-992
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.976
Screening and identification of bioactive compounds from citrus against non-structural protein 3 protease of hepatitis C virus genotype 3a by fluorescence resonance energy transfer assay and mass spectrometry
Mahim Khan, Waqar Rauf, Fazal-e- Habib, Moazur Rahman, Mazhar Iqbal
Mahim Khan, Waqar Rauf, Fazal-e- Habib, Moazur Rahman, Mazhar Iqbal, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering College, Pakistan Institute of Engineering and Applied Sciences (NIBGE-C, PIEAS), Faisalabad 38000, Punjab, Pakistan
Moazur Rahman, School of Biological Sciences, University of the Punjab, Lahore 54810, Punjab, Pakistan
Author contributions: Khan M was involved in this project from the design to execution and writing of this manuscript, optimized the expression and purification of hepatitis C virus non-structural protein 3 protease, extracted antioxidant compounds and tested their inhibition using the in vitro fluorescence resonance energy transfer assay, contributed to the LCMS/MS analysis to identify phenolics/flavonoids in plant extracts and evaluated their interaction using a modeling approach; Rauf W contributed to the design and execution of the experiments and LCMS/MS data analysis; Habib F performed the LCMS/MS analysis; Rahman M provided help with the purification of hepatitis C virus non-structural protein 3 and manuscript writing; Iqbal M conceived the idea, planned all of the experiments, and contributed to the data analysis, and manuscript writing.
Institutional review board statement: It is certified that the protocol of the study, screening and identification of bioactive compounds from citrus against non-structural protein 3 protease of hepatitis C virus genotype 3a by fluorescence resonance energy transfer assay and mass spectrometry was approved by the institutional review board.
Conflict-of-interest statement: There is no financial, commercial or other conflict of interest with any author.
Data sharing statement: All data generated or analyzed during this study are included in this manuscript and its supplementary material. Any additional information, if required, may be asked from the corresponding author (hamzamgondal@ gmail.com).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mazhar Iqbal, PhD, Professor, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering College, Pakistan Institute of Engineering and Applied Sciences (NIBGE-C, PIEAS), Jhang Road, Faisalabad 38000, Punjab, Pakistan. hamzamgondal@gmail.com
Received: July 27, 2020
Peer-review started: July 27, 2020
First decision: August 22, 2020
Revised: September 3, 2020
Accepted: September 16, 2020
Article in press: September 16, 2020
Published online: November 27, 2020
Abstract
BACKGROUND

Hepatitis C virus genotype 3a (HCV G3a) is highly prevalent in Pakistan. Due to the elevated cost of available Food and Drug Administration-approved drugs against HCV, medicinal natural products of potent antiviral activity should be screened for the cost-effective treatment of the disease. Furthermore, from natural products, active compounds against vital HCV proteins like non-structural protein 3 (NS3) protease could be identified to prevent viral proliferation in the host.

AIM

To develop cost-effective HCV genotype 3a NS3 protease inhibitors from citrus fruit extracts.

METHODS

Full-length NS3 without co-factor non-structural protein 4A (NS4A) and codon optimized NS3 protease in fusion with NS4A were expressed in Escherichia coli. The expressed protein was purified by metal ion affinity chromatography and gel filtration. Citrus fruit extracts were screened using fluorescence resonance energy transfer (FRET) assay against the protease and polyphenols were identified as potential inhibitors using electrospray ionization-mass spectrometry (MS)/MS technique. Among different polyphenols, highly potent compounds were screened using molecular modeling approaches and consequently the most active compound was further evaluated against HCV NS4A-NS3 protease domain using FRET assay.

RESULTS

NS4A fused with NS3 protease domain gene was overexpressed and the purified protein yield was high in comparison to the lower yield of the full-length NS3 protein. Furthermore, in enzyme kinetic studies, NS4A fused with NS3 protease proved to be functionally active compared to full-length NS3. So it was concluded that co-factor NS4A fusion is essential for the purification of functionally active protease. FRET assay was developed and validated by the half maximal inhibitory concentration (IC50) values of commercially available inhibitors. Screening of citrus fruit extracts against the native purified fused NS4A-NS3 protease domain showed that the grapefruit mesocarp extract exhibits the highest percentage inhibition 91% of protease activity. Among the compounds identified by LCMS analysis, hesperidin showed strong binding affinity with the protease catalytic triad having S-score value of -10.98.

CONCLUSION

Fused NS4A-NS3 protease is functionally more active, which is effectively inhibited by hesperidin from the grapefruit mesocarp extract with an IC50 value of 23.32 µmol/L.

Keywords: Hepatitis C virus genotype 3a, Non-structural protein 3 protease, Fluorescence resonance energy transfer assay, Citrus extract, Mass spectrometry, Hesperidin

Core Tip: The manuscript describes the screening of active metabolites in citrus fruit extracts against hepatitis C virus genotype3a non-structural protein 3 (HCV-G3a NS3) protease. In this study, conditions have been optimized to get highly purified and functionally active protein HCV NS3. Further, fluorescence resonance energy transfer assay was used to screen the citrus extracts against NS3 protease. By using liquid chromatography coupled with tandem mass spectrometry/mass spectrometry analysis and bioinformatics modeling approaches, the observed activity of citrus extracts against HCV genotype3a NS3 protease was ascribed to hesperidin. Fluorescence resonance energy transfer assay confirmed the inhibitory potential of hesperidin against NS4A-NS3 protease domain with an half maximal inhibitory concentration value of 23.32 µmol/L.